白天节律:对肝脏再生和肝脏再生刺激物质的影响
Science (New York, N.Y.)
|March 10, 1978
概括
控制照明会影响大鼠肝提取物的活性和DNA合成节奏. 虽然内源性DNA合成与光循环同步,但提取物与光循环同步.
科学领域:
- 时间生物学 时间生物学
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
背景情况:
- 昼夜节律影响生理过程,包括肝脏再生.
- 肝脏提取物可以刺激DNA合成,这是组织修复的关键过程.
研究的目的:
- 为了研究受控照明时间表对断奶老鼠肝脏提取的白天节律的影响.
- 为了检查这种提取物如何影响成年大鼠再生肝脏的DNA合成.
- 了解光周期,提取活性和内源DNA合成之间的相互作用.
主要方法:
- 对断奶老鼠实施了受控的照明时间表.
- 测量了这些老鼠肝脏提取物的活性.
- 评估了断奶大鼠的内源DNA合成和成年大鼠再生肝脏的DNA合成.
- 照明时间表被反转,以观察对节律的影响.
主要成果:
- 在断奶大鼠中,肝部提取物的活性和内源性DNA合成都表现出不同的昼间节律.
- 逆转照明时间表改变了内源DNA合成节奏,但破坏了提取物活性和峰值DNA合成之间的相关性.
- 提取物在再生肝脏中持续增强DNA合成,无论手术的日间时间 (肝切除术).
结论:
- 白天节律显著影响肝脏提取物的产生和活性,这些提取物调节DNA合成.
- 虽然光循环调节内源DNA合成,但测试肝提取物对再生肝脏DNA合成的刺激作用似乎不那么依赖于一天中的时间.
- 这表明,在肝脏再生过程中,昼夜因素和特定的分子信号之间存在复杂的相互作用.
相关概念视频
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...